United States · FDA National Drug Code directory
Ondansetron
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-0650_e5cd8042-5934-4ebf-98f2-90e3d5b48beb
- Product NDC
- 71335-0650
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- Ondansetron
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20100412
- Source listing expiry
- 20261231
Source-listed ingredients
- ONDANSETRON — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 90 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-0650-0) · 71335-0650-0
- 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-0650-1) · 71335-0650-1
- 20 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-0650-2) · 71335-0650-2
- 10 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-0650-3) · 71335-0650-3
- 6 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-0650-4) · 71335-0650-4
- 60 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-0650-5) · 71335-0650-5
- 9 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-0650-6) · 71335-0650-6
- 5 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-0650-7) · 71335-0650-7
- 15 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-0650-8) · 71335-0650-8
- 3 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-0650-9) · 71335-0650-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →